Melatonin Over the Counter: Where You Can Buy It Without a Prescription (and Where You Can't)

Written by the Nuvirox Research Team

Short answer: in the United States and Canada, yes—melatonin is freely available over the counter with no prescription required. In the UK, Australia, Japan, and most of the European Union, it is classified as a prescription medicine, and you cannot legally buy it without seeing a doctor. This is not a minor regulatory footnote. It reflects a genuine scientific and policy disagreement about whether a hormone that modulates the circadian system should be available the same way vitamins are. Understanding that disagreement helps you make a better-informed decision about what you're actually taking.

Why is melatonin OTC in the US but prescription-only elsewhere?

The divergence traces almost entirely to one piece of US legislation: the Dietary Supplement Health and Education Act of 1994 (DSHEA). Before DSHEA, the FDA was evaluating melatonin under an investigational new drug (IND) framework, which would have required manufacturers to demonstrate safety and efficacy through clinical trials before sale. DSHEA reclassified melatonin as a dietary supplement, which under US law means it can be marketed without pre-market FDA approval, provided it is not labeled as treating or preventing a specific disease.

That single legislative decision fundamentally changed melatonin's commercial trajectory in the US. From a nearly controlled pharmaceutical candidate, it became a supplement sold next to vitamin C and fish oil—in any dose, in any format, with minimal quality oversight.

Other countries took a different view. The core question their regulators asked was: what is melatonin, biologically? The answer—it is a hormone synthesized by the pineal gland with documented effects on the circadian system, body temperature, reproductive biology, and immune function—led regulators in the UK, Australia, Japan, and most EU member states to treat it as a medicine rather than a food supplement. That classification requires pharmaceutical-grade manufacturing standards, prescriber oversight, and in most cases demonstrated clinical evidence before market authorization.

What does OTC status actually mean for quality and safety?

This is where the practical implications bite. Being classified as a dietary supplement means melatonin products in the US are subject to the FDA's Good Manufacturing Practice (GMP) regulations for supplements—but not the pre-market approval, batch-release testing, or pharmacovigilance requirements that apply to pharmaceutical drugs.

A widely-cited study analyzed 31 melatonin supplements purchased from retailers in Canada (before OTC melatonin sales were restricted there) and found that actual melatonin content ranged from 83% less to 478% more than what the label claimed, with 70% of products deviating by more than 10% from their stated dose. Over a quarter of the products also contained measurable levels of serotonin—a neurotransmitter that, unlike melatonin, can cause adverse reactions even at relatively low doses. This research, published in the Journal of Clinical Sleep Medicine, is the clearest empirical argument for why other countries treat melatonin as a medicine requiring quality controls.

Third-party testing programs (USP, NSF International, Informed Sport) address some of this risk for consumers who seek out tested products, but participation is voluntary and the majority of melatonin products sold in the US have not been independently verified. This is directly relevant to dose: if you think you're taking 3 mg but your supplement actually contains 9 mg, the melatonin physiology changes meaningfully—including next-morning grogginess and potential impacts on your own endogenous melatonin rhythm. For context on what clinical doses are actually supported by evidence, see our article on melatonin dosage.

What happens if you try to bring OTC US melatonin to a prescription-only country?

This is a legitimate concern for travelers. The practical and legal situation is nuanced. In prescription-only countries like the UK and Australia, melatonin is classified as a medicine—which means importing it without a valid local prescription is technically importing an unregistered pharmaceutical. In practice, customs enforcement of small quantities for personal use in original packaging is inconsistent; most travelers carrying a single bottle for personal use will not have it seized. But there is no guarantee, and Japan in particular has stricter pharmaceutical import controls where large quantities could cause problems.

The more important practical point is this: if you travel frequently for work, and you rely on melatonin to manage jet lag across time zones, the EU's approach may actually serve you better. The European Food Safety Authority (EFSA) has specifically authorized a health claim for melatonin—"contributes to the reduction of time taken to fall asleep"—for products containing 1 mg per portion taken close to bedtime. That is a regulated, verified claim backed by a scientific dossier, which the US OTC market does not require. It represents a different model of access, not necessarily a worse one.

What human evidence exists for melatonin as an OTC sleep aid?

The 2013 PLOS ONE meta-analysis (PMCID: PMC3656905): Nineteen randomized controlled trials involving 1,683 participants found melatonin significantly reduced sleep latency by about 7 minutes and increased total sleep time by roughly 8 minutes compared to placebo, with significant improvement in overall sleep quality. These effects, while modest, were consistent and did not appear to diminish with continued use—an important distinction from tolerance-inducing sleep medications.

The counterweight—what OTC melatonin does not do: The same evidence base shows melatonin is most effective for circadian timing problems (jet lag, shift work, delayed sleep phase) rather than for primary chronic insomnia with normal circadian alignment. A neurologist quoted by University Hospitals noted that melatonin reduces sleep latency by "about six minutes, which is not a lot of time considering people sometimes can't fall asleep for 45 minutes, an hour or two hours." People expecting a sedative effect from OTC melatonin—comparable to diphenhydramine (Benadryl), which many drugstores sell next to it—will typically find the effect underwhelming, because melatonin works through a fundamentally different mechanism: circadian signaling rather than CNS depression.

Honest limitations: Many OTC melatonin products contain 5–10 mg per dose—doses that are 15 to 30 times higher than the 0.3 mg dose demonstrated in research to be sufficient for sleep onset support. Higher doses are not necessarily more effective and may suppress the body's own melatonin production over time, though the clinical evidence on this is limited. The fundamental problem with OTC access is not that melatonin is dangerous—it has a very favorable short-term safety profile—but that most OTC users are taking pharmacological doses (5–10+ mg) when physiological doses (0.3–1 mg) are what the evidence supports.

What OTC melatonin won't do

OTC melatonin cannot diagnose or address the underlying cause of chronic insomnia. If you have sleep apnea, restless legs syndrome, circadian rhythm disorders, or depression-related sleep disruption, a bottle from the grocery store will not fix those conditions—and self-treating with melatonin may delay evaluation by a clinician who could identify and treat the actual problem. See a doctor if: your sleep problems have persisted for more than three to four weeks despite consistent sleep habits; you snore loudly or wake up gasping; you feel excessively tired during the day regardless of time in bed; or you suspect your sleep difficulty is linked to mood, anxiety, or a physical condition.

Frequently asked questions

Is melatonin FDA-approved in the US?
No. The FDA classifies melatonin as a dietary supplement, not an approved drug. This means it is not FDA-approved for any specific indication—including sleep. Melatonin receptor agonists like ramelteon (Rozerem) are FDA-approved prescription drugs for insomnia; these are different from melatonin supplements sold OTC.

Can you buy melatonin OTC in Canada?
Yes, at low doses. Canada classifies melatonin as a Natural Health Product, allowing OTC sale, though with somewhat more regulatory structure than the US. Health Canada has been consulting on whether to restrict pediatric melatonin to prescription status, aligning with EU and UK approaches for children.

Can I order US melatonin online if I live in the UK or Australia?
You can find it, but it sits in a legal gray area. Importing an unregistered pharmaceutical into a country that classifies melatonin as prescription-only is technically a customs violation. Packages are sometimes seized. For regular use, the practical path in prescription-only countries is through a GP or online prescriber.

Is the US OTC melatonin market safe?
Short-term use at sensible doses appears safe for most healthy adults. The quality control gap is the main concern—not inherent toxicity, but label inaccuracy. Choosing a third-party tested product (USP verified or NSF certified) substantially reduces the risk of dosing significantly more than you intend. See our article on how to choose the best melatonin for specific criteria.

What dose should I take if I buy OTC melatonin?
The research evidence supports 0.3–1 mg for sleep onset and 0.5–5 mg for jet lag. Most US OTC products contain 3–10 mg, which is above the evidence-based range. Starting at the lowest available dose—or splitting a tablet—is consistent with both the pharmacology and sleep medicine expert guidance.

The bottom line

The US OTC melatonin market is a product of a specific 1994 legislative decision, not a global consensus that melatonin is safely equivalent to a vitamin. The evidence for melatonin's sleep benefits is real but modest, best supported for circadian timing problems rather than general chronic insomnia, and most relevant at doses far below what most OTC products contain. If you use OTC melatonin, choosing a third-party tested product and using the lowest effective dose are the two most evidence-consistent decisions you can make. If you want to understand what clinical evidence supports at the dosing level, see our guide on melatonin dosage and how the low-dose 300 mcg research compares to standard OTC products in our article on melatonin 300 mcg.

References

1. Dietary Supplement Health and Education Act of 1994 (DSHEA). Public Law 103-417. US Congress.
2. Erland LAE, Saxena PK. Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content. J Clin Sleep Med. 2017;13(2):275-281. PMCID: PMC5263069.
3. Ferracioli-Oda E et al. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLOS ONE. 2013;8(5):e63773. PMCID: PMC3656905.
4. European Food Safety Authority (EFSA). Scientific Opinion on the substantiation of a health claim related to melatonin and reduction of sleep onset latency. EFSA Journal. 2011;9(6):2241.
5. Costello RB et al. The effectiveness of melatonin for promoting healthy sleep: a rapid evidence assessment of the literature. Nutr J. 2014;13:106. DOI: 10.1186/1475-2891-13-106.
6. LegalClarity. Is Melatonin Banned in Other Countries? Country Breakdown. April 2026. https://legalclarity.org/is-melatonin-banned-in-other-countries/
7. National Institutes of Health – StatPearls. Melatonin. Updated 2024. https://www.ncbi.nlm.nih.gov/books/NBK534823/

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.